Clinical Trials in Chicago

Showing 16341-16360 of 20,493 trials

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

NCT02255123

This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

Cardiac Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)178 participantsStarted Oct 2014

San Francisco, California, United States • Chicago, Illinois, United States • Maywood, Illinois, United States +9 more locations

TERMINATEDPhase 32.2 miles

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

NCT00580216

The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).

Atrial Fibrillation

Sanofi3,773 participantsStarted Dec 2007

Mobile, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +535 more locations

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Find Trials by Condition in Chicago

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Care Partners: Web-based Support for Caregivers of Veterans Undergoing Chemotherapy

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Elder Surgery - Functional Recovery Following Beta Blockade

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients